@prefix this: . @prefix sub: . @prefix drugbank: . @prefix np: . @prefix mondo: . @prefix pav: . @prefix infores: . @prefix hp: . @prefix xsd: . @prefix ntemplate: . @prefix orcid: . @prefix rdfs: . @prefix pmid: . @prefix ncit: . @prefix rdf: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { drugbank:DB01267 a biolink:Drug; rdfs:label "Paliperidone"; biolink:category biolink:Drug . hp:0000737 a biolink:Disease; rdfs:label "Irritability"; biolink:category biolink:Disease . sub:association rdf:object hp:0000737; rdf:predicate biolink:treats; rdf:subject drugbank:DB01267; a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; rdfs:label "Stigler et al. [10] evaluated the effectiveness and tolerability of paliperidone for irritability in ASD. In this 8-week, prospective, open-label study, 21 (84%) of 25 subjects with ASD (mean age, 15.3 years) were considered responders to paliperidone (mean dosage, 7.1 mg/day), based on Clinical Global Impression (CGI)- Improvement and Aberrant Behaviour Checklist-Irritability sub- scale.v"; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; biolink:has_population_context sub:context; biolink:publications pmid:31096228; biolink:relation ncit:C94303 . sub:context a biolink:Cohort; rdfs:label "Children and adolescents (mean age 15.3 years)"; biolink:category biolink:Cohort; biolink:has_phenotype mondo:0005258 . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "NeH/8kC8VK3DP1/tbL1yIoGGwguuxVycaDYHS/YKAT8vvDD8/+NQBUt+nn0gOEvKZAtEJWG7dx5qf3KUY7GecQ/CYzgiGblTO7a2NDJELGVcI0k13Yb9uAPFcDNvQNIev0YqKJm5J3bUepHbAsFE8iCwoJOwEjVWB9cbIH+gYpk="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-09-16T11:50:42.254483"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-1501-1082; ntemplate:wasCreatedFromTemplate . biolink: pav:version "2.3.0" . }